<DOC>
	<DOCNO>NCT00684047</DOCNO>
	<brief_summary>The purpose study evaluate safety hemostasis effectiveness human plasma-derived fibrin sealant Grifols ( FS Grifols ) peripheral vascular surgery .</brief_summary>
	<brief_title>Safety Efficacy Study Fibrin Sealant Grifols Evaluated Adjunct Hemostasis</brief_title>
	<detailed_description>The trial consist 2 part : Preliminary Part ( I ) Primary Part ( II ) . All subject enrol Preliminary Part ( I ) treat FS Grifols . Subjects Primary Part ( II ) randomly allocate 2:1 ratio treatment FS Grifols manual compression . The objective study evaluate hemostasis effectiveness FS Grifols peripheral vascular surgery assess clinical safety , viral safety , immunogenicity .</detailed_description>
	<mesh_term>Hemostatics</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Are male female Must least 3 year age upper age limit ( must least 18 year age Spain United Kingdom ) Require elective ( nonemergency ) , open ( nonlaparoscopic ; nonendovascular ) peripheral vascular surgical procedure Have hemoglobin ≥ 9.0 g/dL Have platelet count &gt; 70 x 10^3/mm^3 Required one peripheral vascular procedure involve either arterial patch angioplasty arterial anastomosis utilize polytetrafluoroethylene Dacron graft , accord Investigator 's ( surgeon 's ) selection : 1 . Carotid endarterectomy require patch angioplasty 2 . Carotidsubclavian bypass graft 3 . Axillofemoral bypass graft 4 . Abdominal aortic aneurysm resection graft replacement 5 . Aortomesenteric bypass graft 6 . Aortoceliac bypass graft 7 . Aortouniiliac bypass graft 8 . Aortobiiliac bypass graft 9 . Aortounifemoral bypass graft 10 . Aortobifemoral bypass graft 11 . Iliac aneurysm resection graft replacement 12 . Femoral aneurysm resection graft replacement 13 . Femoralfemoral bypass graft 14 . Femoralpopliteal bypass graft 15 . Renal arterial revascularization ( bypass graft ) 16 . Renal arterial revascularization ( endarterectomy patch angioplasty ) 17 . Popliteal artery revascularization ( bypass graft ) 18 . Popliteal artery revascularization ( endarterectomy patch angioplasty ) 19 . Femoral endarterectomy patch angioplasty 20 . Iliofemoral bypass graft Intraoperative inclusion criterion : A Target bleeding site ( TBS ) identify accord Investigator 's judgment , TBS mild moderate arterial bleed accord Investigator 's judgment Weighed &lt; 20 kg Have preoperative ( Baseline Assessments ) international normalize ratio ≥ 2.0 Have preoperative ( Baseline Assessments ) activate partial thromboplastin time ratio ≥ 1.5 Have preoperative ( Baseline Assessments ) serum creatinine &gt; 2 time upper limit normal range Were undergo reoperative procedure arterial patch angioplasty arterial anastomosis Have infection anatomical surgical area Have history severe ( e.g. , anaphylactic ) reaction blood blood derive product Unwilling receive blood product Have positive bleeding history Female pregnant nursing Are know abuse alcohol , opiates , psychotropic agent chemical drug , do within 12 month screen visit . Are currently participate another investigational drug device clinical study , participate within 3 month screen visit . Were previously include clinical trial ( protocol number IG402 )</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Fibrin Sealant</keyword>
	<keyword>Hemostasis</keyword>
	<keyword>Peripheral Vascular Surgery</keyword>
</DOC>